Bevacizumab plus capecitabine versus capecitabine alone in elderly patients with previously untreated metastatic colorectal cancer (AVEX): an open-label, randomised phase 3 trial
David Cunningham(Royal Marsden Hospital), István Láng(National Institute of Oncology), Eugenio Marcuello(Hospital de Sant Pau), Vito Lorusso(Istituto Tumori Bari), Janja Ocvirk(Institute of Oncology Ljubljana), Dong Bok Shin(Deleted Institution), Derek J. Jonker(Ottawa Hospital), Stuart Osborne(Roche (Switzerland)), Niko Andre(Roche (Switzerland)), Daniel Waterkamp(Roche (Switzerland)), Mark Saunders(The Christie Hospital)
Cited by 653
Abstract
Related Papers
No related papers found
Powered by citation graph analysis